Knowledge of vitamin K antagonists’ use in atrial fibrillation patients

Journal Title: Medycyna Ogólna i Nauki o Zdrowiu - Year 2016, Vol 22, Issue 1

Abstract

[b]Introduction.[/b] Vitamin K antagonists (VKA) are a well-known group of antithrombotic agents examined in clinical trials with a proven effect of preventing embolic complications in patients with atrial fibrillation (AF). In order to achieve such an efficacy and safety, it is essential to educate the patients and maintain their strict compliance. [b]Objective.[/b] To examine the level of knowledge about thromboembolism prevention in patients with AF who receive oral anticoagulants – acenocumarol, warfarin – and to assess the regularity of taking the oral anticoagulant and the value of INR as a measure of the effectiveness of the therapy. [b]Material and methods.[/b] The prospective trial included 55 randomly chosen patients asked to fill out a questionnaire created for the purposes of the study. The value of INR at admission was also collected. [b]Results.[/b] Among 55 examined patients, just over a half had the feeling of sufficient knowledge about the drug. Mean test result was 5.76 points out of a possible 13. Only every other patient received written materials regarding the rules of the treatment. The INR value in the therapeutic range was noted in 56.4% of patients. The correct limits of that range were given by only 45.5%. [b]Conclusions.[/b] The level of patients` knowledge about the rules of the therapy with VKA is low. It correlates negatively with age. Older patients require special attention of the physician starting the therapy, a longer time for education, or a more meticulous monitoring of the treatment. Receiving materials about the VKA and INR leads to an increase in patients` knowledge. A better knowledge about the rules of the treatment does not mean keeping the INR value within the therapeutic range. However, it allows patients to participate in the drug dose adjustment.[b]Key words:[/b] atrial fibrillation, anticoagulants, patient education as topic

Authors and Affiliations

Daria Gorczyca-Siudak, Łukasz Siudak, Jerzy Mosiewicz

Keywords

Related Articles

Physical activity is the key to longevity

[b]introduction[/b]. Aging is an irreversible process – a stage of our life. However, aging is determined by a range of different factors affecting the body throughout its lifetime. The demographic aging of our community...

Jakość życia pielęgniarek – badanie wstępne

[b][/b][b]Wstęp.[/b] Jakość życia przejawia się w przystosowaniu biologicznym, społecznym, podmiotowym i duchowym. Z tej perspektywy pojęcie to utożsamiane jest zarówno z wartościami otaczającego świata, jak i z jakością...

Pourazowe obrażenia czaszkowo-mózgowe u pacjentów w stanie nietrzeźwości, przyjmowanych doraźnie do szpitalnego oddziału ratunkowego

[b]Wstęp. [/b]Alkohol etylowy uznawany jest za jeden z najważniejszych czynników ryzyka prowadzących do powstawania urazów czaszkowo-mózgowych. Wśród pacjentów przyjmowanych do Szpitalnego Oddziału Ratunkowego (SOR) dużą...

Kontrowersje związane z diagnozą i leczeniem boreliozy na świecie

[b]Wprowadzenie.[/b] Choroba z Lyme jest najczęstszą chorobą przenoszoną przez kleszcze na świecie i jedną z najbardziej kontrowersyjnych chorób w historii medycyny. Wywołują ją krętki z rodzaju Borrelia, ma przebieg faz...

Persistent Pulmonary Hypertension in Newborns – selected aspects of nursing care in Polish and Australian Neonatal Intensive Care Units

Introduction. Newborns diagnosed with persistent pulmonary hypertension (PPHN) are among the ‘most difficult’ patients of Neonatal Intensive Care Units (NICU). Despite tremendous progress in neonatology, the mortality am...

Download PDF file
  • EP ID EP79523
  • DOI 10.5604/20834543.1198721
  • Views 162
  • Downloads 0

How To Cite

Daria Gorczyca-Siudak, Łukasz Siudak, Jerzy Mosiewicz (2016). Knowledge of vitamin K antagonists’ use in atrial fibrillation patients. Medycyna Ogólna i Nauki o Zdrowiu, 22(1), 33-39. https://europub.co.uk/articles/-A-79523